Cogent Biosciences, Inc. (COGT) Ownership

$39.16

$0.18 (0.46%)
Last update: 04:00 PM EST
Day's range
$38.53
Day's range
$40.08

Cogent Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 22.41 M $321.78 M   31.21% 19.58%
BLACKROCK, INC. 11/12/2025 10.37 M $148.91 M   20.20% 9.06%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2025 9.05 M $130.00 M   242.89% 7.91%
FAIRMOUNT FUNDS MANAGEMENT LLC 11/14/2025 9.00 M $129.29 M   44.62% 7.87%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2025 7.89 M $113.25 M   -7.14% 6.89%
VANGUARD GROUP INC 11/07/2025 7.76 M $111.40 M   18.93% 6.78%
COMMODORE CAPITAL LP 11/14/2025 7.25 M $104.11 M   213.69% 6.33%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 6.80 M $97.62 M   -2.39% 5.94%
STATE STREET CORP 11/14/2025 4.78 M $68.58 M   41.62% 4.17%
VR ADVISER, LLC 11/14/2025 4.00 M $57.44 M   -15.89% 3.49%
RTW INVESTMENTS, LP 11/14/2025 3.47 M $49.79 M   100.00% 3.03%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.27 M $47.03 M   22.53% 2.86%
JANUS HENDERSON GROUP PLC 11/14/2025 3.18 M $45.60 M   10.62% 2.78%
PARADIGM BIOCAPITAL ADVISORS LP 11/14/2025 3.16 M $45.33 M   -69.51% 2.76%
OCTAGON CAPITAL ADVISORS LP 11/14/2025 2.87 M $41.27 M   4.02% 2.51%
VIVO CAPITAL, LLC 11/14/2025 2.79 M $40.05 M   148.48% 2.44%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 2.67 M $38.35 M   100.00% 2.33%
BANK OF AMERICA CORP /DE/ 11/14/2025 2.24 M $32.16 M   59.84% 1.96%
REDMILE GROUP, LLC 11/14/2025 2.21 M $31.72 M   52.56% 1.93%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 2.13 M $30.56 M   -9.66% 1.86%
SATURN V CAPITAL MANAGEMENT LLC 11/14/2025 2.03 M $29.08 M   -11.86% 1.77%
UBS GROUP AG 11/13/2025 1.85 M $26.62 M   -47.32% 1.62%
SIREN, L.L.C. 11/13/2025 1.72 M $24.76 M   101.82% 1.51%
CITADEL ADVISORS LLC 11/14/2025 1.67 M $23.95 M   168.47% 1.46%
GOLDMAN SACHS GROUP INC 11/14/2025 1.66 M $23.83 M   38.26% 1.45%
EMERALD ADVISERS, LLC 10/30/2025 1.58 M $22.68 M   9.25% 1.38%
D. E. SHAW & CO., INC. 11/14/2025 1.53 M $21.98 M   459.68% 1.34%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 1.51 M $21.64 M   -8.98% 1.32%
MORGAN STANLEY 11/14/2025 1.29 M $18.50 M   4.80% 1.13%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 1.24 M $17.78 M   -74.80% 1.08%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.19 M $17.10 M   34.23% 1.04%
NORTHERN TRUST CORP 11/14/2025 1.18 M $16.97 M   26.45% 1.03%
DUQUESNE FAMILY OFFICE LLC 11/14/2025 1.06 M $15.22 M   100.00% 0.93%
EMERALD MUTUAL FUND ADVISERS TRUST 10/30/2025 1.02 M $14.69 M   14.23% 0.89%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2025 1.01 M $14.48 M   26.01% 0.88%
CANDRIAM S.C.A. 11/06/2025 954.21 K $13.70 M   123.29% 0.83%
BOONE CAPITAL MANAGEMENT LLC 11/14/2025 945.04 K $13.57 M   100.00% 0.83%
NUVEEN, LLC 11/12/2025 939.62 K $13.49 M   308.33% 0.82%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2025 815.08 K $11.70 M   100.00% 0.71%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 697.96 K $10.02 M   224.01% 0.61%
MARSHALL WACE, LLP 11/13/2025 642.48 K $9.23 M   100.00% 0.56%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 583.89 K $8.38 M   12.26% 0.51%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 577.00 K $8.29 M   193.40% 0.50%
TREXQUANT INVESTMENT LP 11/14/2025 566.37 K $8.13 M   13.04% 0.49%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 562.00 K $8.07 M   100.00% 0.49%
WOODLINE PARTNERS LP 11/14/2025 513.40 K $7.37 M   -48.69% 0.45%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 500.00 K $7.18 M   100.00% 0.44%
HIGHVISTA STRATEGIES LLC 11/14/2025 462.41 K $6.64 M   63.29% 0.40%
EXOME ASSET MANAGEMENT LLC 11/14/2025 443.55 K $6.37 M   -16.88% 0.39%
MILLENNIUM MANAGEMENT LLC 11/14/2025 414.97 K $5.96 M   -57.22% 0.36%

Cogent Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 238 institutional investors and hedge funds held shares of Cogent Biosciences, Inc.. The most heavily invested institutionals were:

FMR LLC: 22.41 M

BlackRock, Inc.: 10.37 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 9.05 M

Fairmount Funds Management LLC: 9 M

Kynam Capital Management, LP: 7.89 M

VANGUARD GROUP INC: 7.76 M

139.09% of Cogent Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 168.52 M shares in the last 24 months. This purchase volume represents approximately $6.61 B in transactions.